and I guess the other concern is that the trial status is still showing as recruiting, so maybe they haven't got enough data yet?https://www.clinicaltrials.gov/ct2/show/record/NCT03765983
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status